Evidence map›Paper›PMID 34682839›Full record

ArticleJournal of clinical medicine2021

Catheter-Directed Therapies in Patients with Pulmonary Embolism: Predictive Factors of In-Hospital Mortality and Long-Term Follow-Up.

Jesús Ribas, Joana Valcárcel, Esther Alba, Yolanda Ruíz, Daniel Cuartero, Adriana Iriarte, José María Mora-Luján, Marta Huguet, Pau Cerdà, Sergio Martínez-Yélamos and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 77% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Jesús RibasPneumology Department, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.ORCID 0000-0001-7356-4307
Joana ValcárcelBellvitge Biomedical Research Institute (IDIBELL), 08907 Barcelona, Spain.
Esther AlbaBellvitge Biomedical Research Institute (IDIBELL), 08907 Barcelona, Spain.
Yolanda RuízPneumology Department, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.ORCID 0000-0002-1395-7157
Daniel CuarteroBellvitge Biomedical Research Institute (IDIBELL), 08907 Barcelona, Spain.ORCID 0000-0002-3074-3513
Adriana IriarteBellvitge Biomedical Research Institute (IDIBELL), 08907 Barcelona, Spain.
José María Mora-LujánBellvitge Biomedical Research Institute (IDIBELL), 08907 Barcelona, Spain.
Marta HuguetBellvitge Biomedical Research Institute (IDIBELL), 08907 Barcelona, Spain.
Pau CerdàBellvitge Biomedical Research Institute (IDIBELL), 08907 Barcelona, Spain.ORCID 0000-0003-4368-6260
Sergio Martínez-YélamosBellvitge Biomedical Research Institute (IDIBELL), 08907 Barcelona, Spain.ORCID 0000-0001-9889-2040
Xavier CorbellaBellvitge Biomedical Research Institute (IDIBELL), 08907 Barcelona, Spain.ORCID 0000-0001-9889-0272
Salud SantosPneumology Department, Hospital Universitari de Bellvitge, 08907 Barcelona, Spain.ORCID 0000-0002-5835-1028
Antoni Riera-MestreBellvitge Biomedical Research Institute (IDIBELL), 08907 Barcelona, Spain.ORCID 0000-0001-9411-804X
Bellvitge University Hospital · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Catheter-directed therapies (CDT) may be considered for selected patients with pulmonary embolism (PE); (2) Methods: Retrospective observational study including all consecutive patients with acute PE undergoing CDT (mechanical or pharmacomechanical) from January 2010 through December 2020. The aim was to evaluate in-hospital and long-term mortality and its predictive factors; (3) Results: We included 63 patients, 43 (68.3%) with high-risk PE. All patients underwent mechanical CDT and, additionally, 27 (43%) underwent catheter-directed thrombolysis. Twelve (19%) patients received failed systemic thrombolysis (ST) prior to CDT, and an inferior vena cava (IVC) filter was inserted in 28 (44.5%) patients. In-hospital PE-related and all-cause mortality rates were 31.7%; 95% CI 20.6-44.7% and 42.9%; 95% CI 30.5-56%, respectively. In multivariate analysis, age > 70 years and previous ST were strongly associated with PE-related and all-cause mortality, while IVC filter insertion during the CDT was associated with lower mortality rates. After a median follow-up of 40 (12-60) months, 11 more patients died (mortality rate of 60.3%; 95% CI 47.2-72.4%). Long-term survival was significantly higher in patients who received an IVC filter; (4) Conclusions: Age > 70 years and failure of previous ST were associated with mortality in acute PE patients treated with CDT. In-hospital and long-term mortality were lower in patients who received IVC filter insertion.

Indexed as

endovascular proceduresmortalitypulmonary embolismthrombectomythrombolytic therapyvena cava filters

Identifiers

PMID34682839
PMCPMC8537142
OpenAlexW3205015623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.